ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib
Clinical trial NCT03097601 · COMPLETED
Trial details
- NCT number
- NCT03097601
- Sponsor
- Centre Antoine Lacassagne
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-06-02
- Primary completion
- 2019-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.